No insider purchase over the last 90 days. The latest, by 赖春宝, was filed 05 Jun 2025.
SMO ClinPlus Co.,Ltd.: what insiders have been doing
This page follows insider dealings at SMO ClinPlus Co.,Ltd. as filed with SSE / SZSE (CSRC), a company from the Health Care sector. The last twelve months, up to 5 November 2026, brought 3 filings signed by 2 insiders.
There is no open-market purchase to report; the filings show 3 sales worth €445k by 2 insiders. At €437k, the sale published on 5 December 2025 by 上海观由投资发展有限公司-观由昭泰(嘉兴)创业投资合伙企业(有限合伙) is the largest of the period.
The median gap between trade and publication is zero days: most filings appear on the same day. This delay matters because a trade only becomes useful information once it is public. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.
Compared with its exchange (519 companies, median 2 filings), a count of 3 filings is above the norm. Since 2024, the database holds 4 purchases and 3 sales by insiders of the company.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and Vetoquinol SA. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.
Who traded when
BuySaleSince the insiders bought
- +47.2%Entry CN¥31.59 · Close at T+90 CN¥46.50
- +15.1%Entry CN¥27.27 · Close at T+365 CN¥31.40
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 600 shares@ CN¥345.849147.5% of flowA股XSHESZSE:273000000766323650
- 700 shares52.5% of flowA股XSHESZSE:273000000019143800
- 79,700 shares100.0% of flowA股XSHESZSE:173000009866690530
- 20,000 shares40.8% of flowA股XSHESZSE:173000009022257900Canonical exit: 3 Sept 2025 (T+90)
- 30,200 shares59.2% of flowA股XSHESZSE:173000009006916540Canonical exit: 28 Aug 2025 (T+90)
- 1,000 shares65.9% of flowA股XSHESZSE:173000007819032260Canonical exit: 2 Oct 2024 (T+90)
- 500 shares34.1% of flowA股XSHESZSE:173000007787070600Canonical exit: 23 Sept 2024 (T+90)
7 of 7 declarations
About SMO ClinPlus Co.,Ltd.
普蕊斯 is a company operating in the healthcare and pharmaceutical sector. It is listed on the XSHE market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
